Decreased expression of TXNIP predicts poor prognosis in patients with clear cell renal cell carcinoma

Accumulating evidence has demonstrated that thioredoxin interacting protein (TXNIP) is abnormally expressed in a variety of malignant tumors and functions as a tumor suppressor. However, the association between TXNIP and clear cell renal cell carcinoma (CCRCC) has not yet been fully elucidated. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Yuan, Qi, Jin-Chun, Li, Xiaoyu, Sun, Jian-Ping, Ji, Hong, Li, Qing-Huai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924160/
https://www.ncbi.nlm.nih.gov/pubmed/31897192
http://dx.doi.org/10.3892/ol.2019.11165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6924160/
https://www.ncbi.nlm.nih.gov/pubmed/31897192
http://dx.doi.org/10.3892/ol.2019.11165

Ejemplares similares